Cargando…

Inflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative Disorders

BACKGROUND AND OBJECTIVES: Neuroinflammation contributes to Parkinson disease (PD) pathology, and inflammatory biomarkers may aid in PD diagnosis. Proximity extension assay (PEA) technology is a promising method for multiplex analysis of inflammatory markers. Neuroinflammation also plays a role in r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedersen, Camilla Christina, Ushakova, Anastasia, Skogseth, Ragnhild Eide, Alves, Guido, Tysnes, Ole-Bjørn, Aarsland, Dag, Lange, Johannes, Maple-Grødem, Jodi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231912/ https://www.ncbi.nlm.nih.gov/pubmed/37258413 http://dx.doi.org/10.1212/NXI.0000000000200132

Ejemplares similares

Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Association of GBA Genotype With Motor and Functional Decline in Patients With Newly Diagnosed Parkinson Disease
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
por: Erga, Aleksander H., et al.
Publicado: (2018)

Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Parkinson’s disease clinical milestones and mortality
por: Gonzalez, Maria Camila, et al.
Publicado: (2022)

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Association of a BACE1 Gene Polymorphism with Parkinson's Disease in a Norwegian Population
por: Lange, Johannes, et al.
Publicado: (2015)

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Pedersen, Camilla Christina, et al.
Publicado: (2021)

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection
por: Gjerstad, Michaela D., et al.
Publicado: (2018)

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease
por: Gaare, Johannes J., et al.
Publicado: (2018)

Development and validation of prognostic survival models in newly diagnosed Parkinson's disease
por: Macleod, Angus D., et al.
Publicado: (2017)

Genetic risk scores and hallucinations in patients with Parkinson disease
por: Kusters, Cynthia D.J., et al.
Publicado: (2020)

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid
por: Oftedal, Linn, et al.
Publicado: (2020)

Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
por: Tufekcioglu, Zeynep, et al.
Publicado: (2023)

Evolution of impulsive–compulsive behaviors and cognition in Parkinson’s disease
por: Erga, Aleksander H., et al.
Publicado: (2019)

Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts
por: Maple-Grødem, Jodi, et al.
Publicado: (2021)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
por: Mulugeta, Ezra, et al.
Publicado: (2011)

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study
por: Szwedo, Aleksandra A., et al.
Publicado: (2022)

Reliability of Three Disability Scales for Detection of Independence Loss in Parkinson's Disease
por: Bjornestad, Anders, et al.
Publicado: (2016)

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study
por: Rongve, A, et al.
Publicado: (2016)

The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
por: Counsell, Carl, et al.
Publicado: (2022)

Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
por: Dick, Fiona, et al.
Publicado: (2023)

Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study
por: Erga, Aleksander H., et al.
Publicado: (2017)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
por: Green, Samantha, et al.
Publicado: (2021)

Development of a constitutive and an auto-inducible high-yield expression system for recombinant protein production in the microalga Nannochloropsis oceanica
por: de Grahl, Imke, et al.
Publicado: (2020)

Differential transcript usage in the Parkinson’s disease brain
por: Dick, Fiona, et al.
Publicado: (2020)

Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort
por: Selvackadunco, Sashika, et al.
Publicado: (2019)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Early constipation predicts faster dementia onset in Parkinson’s disease
por: Camacho, M., et al.
Publicado: (2021)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
por: Nido, Gonzalo S., et al.
Publicado: (2020)

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
por: Toker, Lilah, et al.
Publicado: (2021)

Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA
por: Guitton, Romain, et al.
Publicado: (2022)

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci
por: Gaare, Johannes Jernqvist, et al.
Publicado: (2020)

NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study
por: Brakedal, Brage, et al.
Publicado: (2021)

Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood-brain barrier
por: Jakubec, Martin, et al.
Publicado: (2020)

Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
por: Rosario, Dorines, et al.
Publicado: (2020)

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
por: Gaare, Johannes J, et al.
Publicado: (2018)

Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
por: Killick, Richard, et al.
Publicado: (2023)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gpokvr6c5q6iucm3td1mcp0v0o